133
Views
15
CrossRef citations to date
0
Altmetric
Review

Safety of antidepressants in the elderly

, , , , , & show all
Pages 367-383 | Published online: 03 Mar 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Seetal Dodd, Gin S. Malhi, John Tiller, Isaac Schweitzer, Ian Hickie, Jon Paul Khoo, Darryl L. Bassett, Bill Lyndon, Philip B. Mitchell, Gordon Parker, Paul B. Fitzgerald, Marc Udina, Ajeet Singh, Steven Moylan, Francesco Giorlando, Carolyn Doughty, Christopher G. Davey, Michael Theodoros & Michael Berk. (2011) A consensus statement for safety monitoring guidelines of treatments for major depressive disorder. Australian and New Zealand Journal of Psychiatry 45:9, pages 712-725.
Read now
Kathleen Ell. (2006) Depression Care for the Elderly: Reducing Barriers to Evidence-Based Practice. Home Health Care Services Quarterly 25:1-2, pages 115-148.
Read now

Articles from other publishers (13)

Kripa Balaram & Silpa Balachandran. (2022) Psychopharmacology in the Elderly. Psychiatric Clinics of North America 45:4, pages 735-744.
Crossref
Brandon Passano, Christian T. Oakley, Vivek Singh, Katherine A. Lygrisse, Ran Schwarzkopf & Claudette M. Lajam. (2022) Documented and Undocumented Psychiatric Conditions Affect the Length of Stay and Discharge Disposition Following Total Hip Arthroplasty. The Journal of Arthroplasty 37:4, pages 727-733.
Crossref
Kristen Cannon. 2021. Absolute Geriatric Psychiatry Review. Absolute Geriatric Psychiatry Review 295 310 .
Catherine E. Prado, Stephanie Watt & Simon F. Crowe. (2018) A meta-analysis of the effects of antidepressants on cognitive functioning in depressed and non-depressed samples. Neuropsychology Review 28:1, pages 32-72.
Crossref
Sophie Corbineau, Marie Breton, Jeanne Mialet-Perez & Jean-François Costemale-Lacoste. (2017) Major depression and heart failure: Interest of monoamine oxidase inhibitors. International Journal of Cardiology 247, pages 1-6.
Crossref
Gregory HouseGrigore BurdeaKevin PolisticoNamrata GrampurohitDoru RollFrank DamianiSamantha KeelerJasdeep Hundal. (2016) A Rehabilitation First—Tournament Between Teams of Nursing Home Residents with Chronic Stroke. Games for Health Journal 5:1, pages 75-83.
Crossref
Brian H. Harvey & Francois N. Slabbert. (2014) New insights on the antidepressant discontinuation syndrome. Human Psychopharmacology: Clinical and Experimental 29:6, pages 503-516.
Crossref
B. Griene, E. Bouajina, M. Haddad, A. Ladjouze, F. Marouan, M. Nejmi, M. R. Ouazzani Taibi & S. Zekri. (2011) Traitement médicamenteux des douleurs neuropathiques périphériques : recommandations d’un groupe d’experts pour le Maghreb francophonePharmacological treatment of peripheral neuropathic pain: expert panel recommendations for the French-speaking maghrebian region. Douleur et Analgésie 24:2, pages 112-120.
Crossref
S Bohlega, T Alsaadi, A Amir, H Hosny, AM Karawagh, D Moulin, N Riachi, A Salti & S Shelbaya. (2010) Guidelines for the Pharmacological Treatment of Peripheral Neuropathic Pain: Expert Panel Recommendations for the Middle East Region. Journal of International Medical Research 38:2, pages 295-317.
Crossref
Anne Dekeyne & Mark J. Millan. (2008) Discriminative stimulus properties of the “atypical” antidepressant, mirtazapine, in rats: a pharmacological characterization. Psychopharmacology 203:2, pages 329-341.
Crossref
John J. Barry, Alan B. Ettinger, Peggy Friel, Frank G. Gilliam, Cynthia L. Harden, Bruce Hermann, Andres M. Kanner, Rochelle Caplan, Sigita Plioplys, Jay Salpekar, David Dunn, Joan Austin & Jana Jones. (2008) Consensus statement: The evaluation and treatment of people with epilepsy and affective disorders. Epilepsy & Behavior 13, pages S1-S29.
Crossref
Paul F. Gallagher, Pat J. Barry, Cristin Ryan, Irene Hartigan & Denis O'Mahony. (2008) Inappropriate prescribing in an acutely ill population of elderly patients as determined by Beers' Criteria. Age and Ageing 37:1, pages 96-101.
Crossref
Mark J. Millan. (2006) Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacology & Therapeutics 110:2, pages 135-370.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.